Work begins on international recall standard
This article was originally published in SRA
International standards body ISO is aiming to publish in 2012 a new standard on the recall of unsafe products1. The current thinking is that products such as pharmaceuticals and medical devices will be included in the standard2 – ISO 10393 – which will provide a code of good practice for establishing, implementing and managing efficient, flexible and responsive consumer product recall programmes, including corrective actions.
You may also be interested in...
The sponsors of up to seven new drugs or vaccines will find out this week whether their products will soon be approved in the EU. The products include two vaccines from Sanofi and what is possibly the first generic rival to Bayer's Xarelto to be assessed by the European Medicines Agency.
Takeda will soon seek EU approval of its dengue vaccine candidate. The marketing application will be fast-tracked, as will the applications for Regeneron's evinacumab and bluebird bio's eli-cel Lenti-D gene therapy.
New medicines under evaluation at the European Medicines Agency.